The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Survival and dementia in GBA ‐associated Parkinson's disease: The mutation matters
Abstract
Objective: The objective of this work was to investigate survival, dementia, and genotype‐phenotype correlations in patients with Parkinson's disease (PD) with and without mutations on the glucocerebrosidase gene ( GBA ). Methods: We included 2,764 unrelated consecutive PD patients: 123 GBA carriers (67 mild‐p.N370S and 56 severe mainly p.L444P) and 2,641 noncarriers. Brain perfusion and dopamine transporter imaging was analyzed, including dementia with Lewy Bodies (DLB) as an additional control group. Results: Multivariable analysis adjusted by sex, age at onset, and disease duration attributed to GBA carriers a greater risk for dementia (hazard ratio [HR] = 3.16; p < 0.001) and death (HR = 1.85; p = 0.002) than noncarriers. When dementia was introduced in the model as a time‐dependent covariate, the mortality risk remained greater in carriers (HR = 1.65; p = 0.016), suggesting that other clinical features are likely to contribute to reduced survival. At last examination, GBA carriers had worse motor symptoms, particularly nondopaminergic features. Carriers of severe mutations had greater risk for dementia compared to mild mutations ( p < 0.001), but similar mortality risk. Consistent with clinical data, GBA carriers showed reduced posterior parietal and occipital cortical synaptic activity and nigrostriatal function than PD noncarriers. Neuroimaging features of carriers of mild mutations overlapped with PD noncarriers, whereas carriers of severe mutations were closer to DLB. Interpretation: Survival is reduced in GBA carriers compared to noncarriers; this seems to be partially independent from the increased risk for early dementia. The risk for dementia is strongly modulated by type of mutation. In the clinical continuum between PD and DLB, patients with GBA mutations seem to localize midway, with carriers of severe mutations closer to DLB than to idiopathic PD. Ann Neurol 2016;80:662–673
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hughes, A. J., Daniel, S. E., Kilford, L., & Lees, A. J. (1992) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.55.3.181 · Cited by 10,378
Diagnosis and management of dementia with Lewy bodies: Third report of the DLB consortium
McKeith, I. G., Dickson, D. W., Lowe, J., Emre, M., O'Brien, J. T., Feldman, H., Cummings, J., Duda, J. E., Lippa, C., Perry, E. K., et al. (2005) · Neurology · doi:10.1212/01.wnl.0000187889.17253.b1 · Cited by 5,069
Multicenter Analysis of Glucocerebrosidase Mutations in Parkinson's Disease
Sidransky, E., Nalls, M. A., Aasly, J. O., Aharon-Peretz, J., Annesi, G., Barbosa, E. R., Bar-Shira, A., Berg, D., Bras, J., Brice, A., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0901281 · Cited by 2,135
Lees, A. J., Hardy, J., & Revesz, T. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60492-x · Cited by 1,956
A systematic review of prevalence studies of dementia in Parkinson's disease
Aarsland, D., Zaccai, J., & Brayne, C. (2005) · Movement Disorders · doi:10.1002/mds.20527 · Cited by 1,689
Mazzulli, J. R., Xu, Y.-H., Sun, Y., Knight, A. L., McLean, P. J., Caldwell, G. A., Sidransky, E., Grabowski, G. A., & Krainc, D. (2011) · Cell · doi:10.1016/j.cell.2011.06.001 · Cited by 1,341
Improved accuracy of clinical diagnosis of Lewy body Parkinson’s disease
Hughes, A. J., Daniel, S. E., & Lees, A. J. (2001) · Neurology · doi:10.1212/wnl.57.8.1497 · Cited by 807
Glucocerebrosidase mutations in clinical and pathologically proven Parkinson’s disease
Neumann, J., Bras, J., Deas, E., O'Sullivan, S. S., Parkkinen, L., Lachmann, R. H., Li, A., Holton, J., Guerreiro, R., Paudel, R., et al. (2009) · Brain · doi:10.1093/brain/awp044 · Cited by 696
The CamPaIGN study of Parkinson's disease: 10-year outlook in an incident population-based cohort
Williams-Gray, C. H., Mason, S. L., Evans, J. R., Foltynie, T., Brayne, C., Robbins, T. W., & Barker, R. A. (2013) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2013-305277 · Cited by 681
Neuropathology provides clues to the pathophysiology of Gaucher disease
Wong, K., Sidransky, E., Verma, A., Mixon, T., Sandberg, G. D., Wakefield, L. K., Morrison, A., Lwin, A., Colegial, C., Allman, J. M., et al. (2004) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2004.04.011 · Cited by 452
Differential effects of severe vs mild GBA mutations on Parkinson disease
Gan-Or, Z., Amshalom, I., Kilarski, L. L., Bar-Shira, A., Gana-Weisz, M., Mirelman, A., Marder, K., Bressman, S., Giladi, N., & Orr-Urtreger, A. (2015) · Neurology · doi:10.1212/wnl.0000000000001315 · Cited by 364
Mortality in Parkinson's disease: A systematic review and meta‐analysis
Macleod, A. D., Taylor, K. S. M., & Counsell, C. E. (2014) · Movement Disorders · doi:10.1002/mds.25898 · Cited by 328 · cited 1×
“Dementia Dementia is the major complication in PD course that greatly affects quality of life and survival.(22) Our multivariable analysis adjusted for sex, age at onset, and disease duration revealed a 3.”
BackgroundMcNeill, A., Magalhaes, J., Shen, C., Chau, K.-Y., Hughes, D., Mehta, A., Foltynie, T., Cooper, J. M., Abramov, A. Y., Gegg, M., et al. (2014) · Brain · doi:10.1093/brain/awu020 · Cited by 321
What predicts mortality in Parkinson disease?: A prospective population-based long-term study
Forsaa, E. B., Larsen, J. P., Wentzel-Larsen, T., & Alves, G. (2010) · Neurology · doi:10.1212/wnl.0b013e3181f61311 · Cited by 302
Lim, S. M., Katsifis, A., Villemagne, V. L., Best, R., Jones, G., Saling, M., Bradshaw, J., Merory, J., Woodward, M., Hopwood, M., et al. (2009) · Journal of Nuclear Medicine · doi:10.2967/jnumed.109.065870 · Cited by 301
Winder-Rhodes, S. E., Evans, J. R., Ban, M., Mason, S. L., Williams-Gray, C. H., Foltynie, T., Duran, R., Mencacci, N. E., Sawcer, S. J., & Barker, R. A. (2013) · Brain · doi:10.1093/brain/aws318 · Cited by 290
Lesage, S., Anheim, M., Condroyer, C., Pollak, P., Durif, F., Dupuits, C., Viallet, F., Lohmann, E., Corvol, J.-C., Honoré, A., et al. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddq454 · Cited by 287
GBA-associated PD presents with nonmotor characteristics
Brockmann, K., Srulijes, K., Hauser, A.-K., Schulte, C., Csoti, I., Gasser, T., & Berg, D. (2011) · Neurology · doi:10.1212/wnl.0b013e318225ab77 · Cited by 268
Brockmann, K., Srulijes, K., Pflederer, S., Hauser, A., Schulte, C., Maetzler, W., Gasser, T., & Berg, D. (2015) · Movement Disorders · doi:10.1002/mds.26071 · Cited by 267
Cognitive performance of GBA mutation carriers with early-onset PD: The CORE-PD study
Alcalay, R. N., Caccappolo, E., Mejia-Santana, H., Tang, M.-X., Rosado, L., Orbe Reilly, M., Ruiz, D., Ross, B., Verbitsky, M., Kisselev, S., et al. (2012) · Neurology · doi:10.1212/wnl.0b013e318253d54b · Cited by 262
Hematologically important mutations: Gaucher disease
Beutler, E., Gelbart, T., & Scott, C. R. (2005) · Blood Cells, Molecules, and Diseases · doi:10.1016/j.bcmd.2005.07.005 · Cited by 241
Motor impairment in PD: Relationship to incident dementia and age
Levy, G., Tang, M.-X., Cote, L. J., Louis, E. D., Alfaro, B., Mejia, H., Stern, Y., & Marder, K. (2000) · Neurology · doi:10.1212/wnl.55.4.539 · Cited by 225
Glucocerebrosidase and Parkinson disease: Recent advances
Schapira, A. H. V. (2015) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2015.03.013 · Cited by 219
Glucocerebrosidase Gene Mutations: A Risk Factor for Lewy Body Disorders
Mata, I. F., Samii, A., Schneer, S. H., Roberts, J. W., Griffith, A., Leis, B. C., Schellenberg, G. D., Sidransky, E., Bird, T. D., Leverenz, J. B., et al. (2008) · Archives of Neurology · doi:10.1001/archneurol.2007.68 · Cited by 207
GBA Variants are associated with a distinct pattern of cognitive deficits in Parkinson's disease
Mata, I. F., Leverenz, J. B., Weintraub, D., Trojanowski, J. Q., Chen‐Plotkin, A., Van Deerlin, V. M., Ritz, B., Rausch, R., Factor, S. A., Wood‐Siverio, C., et al. (2016) · Movement Disorders · doi:10.1002/mds.26359 · Cited by 204
Striatal dopamine transporter in dementia with Lewy bodies and Parkinson disease: A comparison
Walker, Z., Costa, D. C., Walker, R. W. H., Lee, L., Livingston, G., Jaros, E., Perry, R., McKeith, I., & Katona, C. L. E. (2004) · Neurology · doi:10.1212/01.wnl.0000123248.39847.1d · Cited by 171
Glucocerebrosidase mutations confer a greater risk of dementia during Parkinson's disease course
Setó‐Salvia, N., Pagonabarraga, J., Houlden, H., Pascual‐Sedano, B., Dols‐Icardo, O., Tucci, A., Paisán‐Ruiz, C., Campolongo, A., Antón‐Aguirre, S., Martín, I. R., et al. (2011) · Movement Disorders · doi:10.1002/mds.24045 · Cited by 166
Cilia, R., Ko, J. H., Cho, S. S., van Eimeren, T., Marotta, G., Pellecchia, G., Pezzoli, G., Antonini, A., & Strafella, A. P. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.03.013 · Cited by 159
Self-citationRegional cerebral blood flow in Parkinson disease with nonpsychotic visual hallucinations
Oishi, N., Udaka, F., Kameyama, M., Sawamoto, N., Hashikawa, K., & Fukuyama, H. (2005) · Neurology · doi:10.1212/01.wnl.0000187116.13370.e0 · Cited by 137
Cilia, R., Cho, S. S., van Eimeren, T., Marotta, G., Siri, C., Ko, J. H., Pellecchia, G., Pezzoli, G., Antonini, A., & Strafella, A. P. (2011) · Movement Disorders · doi:10.1002/mds.23480 · Cited by 129
Self-citationNobili, F. M., Naseri, M. S. Z., Carli, F. D., Asenbaum, S., Booij, J., Darcourt, J., Ell, P. J., Kapucu, Ö., Kemp, P. M., Claus, V., et al. (2012) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-012-2304-8 · Cited by 117
Impact of glucocerebrosidase mutations on motor and nonmotor complications in Parkinson's disease
Oeda, T., Umemura, A., Mori, Y., Tomita, S., Kohsaka, M., Park, K., Inoue, K., Fujimura, H., Hasegawa, H., Sugiyama, H., et al. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2015.08.027 · Cited by 114
Ambrosi, G., Ghezzi, C., Zangaglia, R., Levandis, G., Pacchetti, C., & Blandini, F. (2015) · Neurobiology of Disease · doi:10.1016/j.nbd.2015.06.008 · Cited by 102
Dementia in Parkinson's disease: Is male gender a risk factor?
Cereda, E., Cilia, R., Klersy, C., Siri, C., Pozzi, B., Reali, E., Colombo, A., Zecchinelli, A., Mariani, C. B., Tesei, S., et al. (2016) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2016.02.024 · Cited by 98
Self-citationGöker-Alpan, Ö., Masdeu, J. C., Kohn, P. D., Ianni, A. M., Lopez, G. J., Groden, C. A., Chapman, M. C., Cropp, B., Eisenberg, D. P., Maniwang, E., et al. (2012) · Brain · doi:10.1093/brain/aws174 · Cited by 90
Parkinson's disease beyond 20 years
Cilia, R., Cereda, E., Klersy, C., Canesi, M., Zecchinelli, A., Mariani, C. B., Tesei, S., Sacilotto, G., Meucci, N., Zini, M., et al. (2014) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2014-308786 · Cited by 76
Self-citationAdvances in GBA-associated Parkinson's disease – Pathology, presentation and therapies
Barkhuizen, M., Anderson, D. G., & Grobler, A. (2015) · Neurochemistry International · doi:10.1016/j.neuint.2015.12.004 · Cited by 68
Glucocerebrosidase mutations in primary parkinsonism
Asselta, R., Rimoldi, V., Siri, C., Cilia, R., Guella, I., Tesei, S., Soldà, G., Pezzoli, G., Duga, S., & Goldwurm, S. (2014) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2014.09.003 · Cited by 66
Self-citationGBA Mutations Are Associated With Earlier Onset and Male Sex in Dementia With Lewy Bodies
Gámez‐Valero, A., Prada-Dacasa, P., dos Santos, C. M. P., Adame-Castillo, C., Campdelacreu, J., Reñé, R., Gascón‐Bayarri, J., Ispierto, L., Álvarez, R., Ariza, A., et al. (2016) · Movement Disorders · doi:10.1002/mds.26593 · Cited by 45
Crosiers, D., Verstraeten, A., Wauters, E., Engelborghs, S., Peeters, K., Mattheijssens, M., Deyn, P. P. D., Theuns, J., Broeckhoven, C. V., & Cras, P. P. (2016) · Neuroscience Letters · doi:10.1016/j.neulet.2016.07.008 · Cited by 32
Cited by
Poewe, W., Seppi, K., Tanner, C. M., Halliday, G. M., Brundin, P., Volkmann, J., Schrag, A.-E., & Lang, A. E. (2017) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.13 · Cited by 5,415
Cognitive decline in Parkinson disease
Aarsland, D., Creese, B., Politis, M., Chaudhuri, K. R., ffytche, D. H., Weintraub, D., & Ballard, C. (2017) · Nature Reviews Neurology · doi:10.1038/nrneurol.2017.27 · Cited by 1,027
A Review of Gaucher Disease Pathophysiology, Clinical Presentation and Treatments
Stirnemann, J., Belmatoug, N., Camou, F., Serratrice, C., Froissart, R., Caillaud, C., Levade, T., Astudillo, L., Serratrice, J., Brassier, A., et al. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18020441 · Cited by 868
The genetics of Parkinson disease
Deng, H., Wang, P., & Jankovic, J. (2018) · Ageing Research Reviews · doi:10.1016/j.arr.2017.12.007 · Cited by 530
GBA, Gaucher Disease, and Parkinson’s Disease: From Genetic to Clinic to New Therapeutic Approaches
Riboldi, G. M., & Di Fonzo, A. B. (2019) · Cells · doi:10.3390/cells8040364 · Cited by 274
Metadata
- Authors
- Cilia, R., Tunesi, S., Marotta, G., Cereda, E., Siri, C., Tesei, S., Zecchinelli, A. L., Canesi, M., Mariani, C. B., Meucci, N., Sacilotto, G., Zini, M., Barichella, M., Magnani, C., Duga, S., Asselta, R., Soldà, G., Seresini, A., Seia, M., Pezzoli, G., & Goldwurm, S.
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 2016-10-03
- Volume
- 80
- Issue
- 5
- Pages
- 662-673
- ISSN
- 0364-5134 (ISSN-L)
- 1531-8249
- OpenAlex
- W2523238466
- Cited by
- 406
- References
- 40
- FWCI
- 20.53
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.